Celli, Bartolome R.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Bartolome R. Celli
Celli, Bartolomé
VIAF ID: 25830765 (Personal)
Permalink: http://viaf.org/viaf/25830765
Preferred Forms
-
100 0 _
‡a
Bartolome R. Celli
-
100 1 _ ‡a Celli, Bartolome R
-
100 1 _
‡a
Celli, Bartolome R.
-
100 1 _
‡a
Celli, Bartolome R.
-
100 1 _
‡a
Celli, Bartolome R.
-
100 1 _
‡a
Celli, Bartolome R.
-
100 1 _ ‡a Celli, Bartolome R.
-
100 1 _ ‡a Celli, Bartolome R.
-
100 1 _
‡a
Celli, Bartolome R.
(sparse)
-
100 1 _ ‡a Celli, Bartolome R.
-
100 1 _ ‡a Celli, Bartolome R.
-
100 1 _ ‡a Celli, Bartolome R.
-
100 1 0
‡a
Celli, Bartolomé
4xx's: Alternate Name Forms (7)
Works
| Title | Sources |
|---|---|
| Apnea del sueño |
|
| Asma |
|
| ATS Study program : EPOC y corticosteroides |
|
| Benralizumab for the Prevention of COPD Exacerbations |
|
| Cáncer de pulmón |
|
| Cuidados intensivos respiratorios |
|
| The Effect of Low Dose Corticosteroids and Theophylline on the Risk of Acute Exacerbations of COPD. The TASCS Randomised Controlled Trial |
|
| Enfermedad pulmonar obstructiva crónica |
|
| Enfermedades pulmonares vasculares |
|
| Enfermedades respiratorias 2008 IV symposium : libro de ponencias |
|
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 |
|
| It is time for the world to take COPD seriously: a statement from the GOLD board of directors |
|
| Jakie leczenie farmakologiczne najskuteczniej zapobiega zaostrzeniom POChP? : komentarz do badania INSPIRE i ostatnich przeglądów systematycznych Cochrane |
|
| Longitudinal change in the BODE index predicts mortality in severe emphysema |
|
| Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial |
|
| Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort |
|
| The most beautiful COPD chart in the world: All Together to End COPD |
|
| Muscle loss in COPD: An 'imploding' phenotype in need of therapies |
|
| Neumonía adquirida en la comunidad |
|
| Nuevas evidencias en el curso clínico de la EPOC |
|
| An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. |
|
| Pharmacotherapy in chronic obstructive pulmonary disease |
|
| Pulmonary function and exercise testing |
|
| Pulmonary rehabilitation, c2000: |
|
| Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial |
|
| Somatotypes trajectories during adulthood and their association with COPD phenotypes |
|
| Standardy rozpoznawania i leczenia chorych na POChP |
|
| Targeting dyspnoea in patients with very severe COPD: Practical precision medicine |
|
| Time for a change: anticipating the diagnosis and treatment of COPD |
|
| Urgent need of a management plan for survivors of COVID-19 |
|
| 慢性閉塞性肺疾患 |
|
